Sihuan Pharmaceutical and Shenzhen Origin Medicines Collaborate to Launch AI R&D Venture, Pioneering AI-Powered Medical Beauty Innovations
2025-09-01 / Read about 0 minute
Author:小编   

Sihuan Pharmaceutical and Shenzhen Origin Medicines have inked a framework agreement to jointly establish an AI R&D company, spearheaded by Sihuan Pharmaceutical. This partnership aims to advance the integration of AI in the research and development of medical beauty products, signifying a pivotal step in Sihuan Pharmaceutical's strategic expansion into the realm of "AI + medical beauty".

  • C114 Communication Network
  • Communication Home
7 X 24 Track global technological trends
Hot Topic